RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study

      한글로보기

      https://www.riss.kr/link?id=A105480769

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background/Aims: Venous thromboembolism (VTE) is a major extraintestinal manifestation in inflammatory bowel disease (IBD), regarded as an independent risk factor for VTE according to reports from Western countries. However, the incidence and risk fac...

      Background/Aims: Venous thromboembolism (VTE) is a major extraintestinal manifestation in inflammatory bowel disease (IBD), regarded as an independent risk factor for VTE according to reports from Western countries. However, the incidence and risk factors of VTE in Asian IBD patients are not fully understood. We aimed to reveal the incidence and risk factors of VTE in Japanese IBD inpatients. Methods: The incidence of VTE in inpatients with IBD (n=340), gastrointestinal cancers (n=557), and other gastrointestinal diseases (n=569) treated at our hospital from 2009 to 2013 was retrospectively investigated. The characteristics and laboratory data of IBD inpatients with and without VTE were compared in univariate and multivariate analyses. Clinical courses of VTE in IBD were surveyed. Results: VTE was detected in 7.1% of IBD inpatients, significantly higher than in gastrointestinal cancer inpatients (2.5%) and inpatients with other gastrointestinal diseases (0.88%). The incidence of VTE in ulcerative colitis (UC) patients (16.7%) was much higher than that in those with Crohn’s disease (3.6%). In the univariate analysis, the risk factors were an older age, central venous catheter, prednisolone, surgery, low serum albumin, high serum C-reactive protein and D-dimer. According to a multivariate analysis, >50 years of age and surgery were the only risk factors. The in-hospital mortality rate of IBD inpatients with VTE was 4.2%. Conclusions: The incidence of VTE with IBD, especially UC, was found to be high compared with other digestive disease, which was almost equivalent to that of Western countries. The efficacy of prophylaxis needs to be investigated in Asian IBD patients.

      더보기

      참고문헌 (Reference)

      1 Grainge MJ, "Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study" 375 : 657-663, 2010

      2 Talbot RW, "Vascular complications of inflammatory bowel disease" 61 : 140-145, 1986

      3 Zitomersky NL, "Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention" 17 : 458-470, 2011

      4 Webberley MJ, "Thromboembolism in inflammatory bowel disease: role of platelets" 34 : 247-251, 1993

      5 Sinagra E, "The role of portal vein thrombosis in the clinical course of inflammatory bowel diseases: report on three cases and review of the literature" 2012 : 916428-, 2012

      6 Heit JA, "The epidemiology of venous thromboembolism in the community: implications for prevention and management" 21 : 23-29, 2006

      7 Fichera A, "Superior mesenteric vein thrombosis after colectomy for inflammatory bowel disease: a not uncommon cause of postoperative acute abdominal pain" 46 : 643-648, 2003

      8 Nguyen GC, "Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients" 103 : 2272-2280, 2008

      9 Papa A, "Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing" 21 : 1204-1213, 2015

      10 Alatri A, "Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort" 51 : 1200-1205, 2016

      1 Grainge MJ, "Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study" 375 : 657-663, 2010

      2 Talbot RW, "Vascular complications of inflammatory bowel disease" 61 : 140-145, 1986

      3 Zitomersky NL, "Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention" 17 : 458-470, 2011

      4 Webberley MJ, "Thromboembolism in inflammatory bowel disease: role of platelets" 34 : 247-251, 1993

      5 Sinagra E, "The role of portal vein thrombosis in the clinical course of inflammatory bowel diseases: report on three cases and review of the literature" 2012 : 916428-, 2012

      6 Heit JA, "The epidemiology of venous thromboembolism in the community: implications for prevention and management" 21 : 23-29, 2006

      7 Fichera A, "Superior mesenteric vein thrombosis after colectomy for inflammatory bowel disease: a not uncommon cause of postoperative acute abdominal pain" 46 : 643-648, 2003

      8 Nguyen GC, "Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients" 103 : 2272-2280, 2008

      9 Papa A, "Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing" 21 : 1204-1213, 2015

      10 Alatri A, "Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort" 51 : 1200-1205, 2016

      11 Purnak T, "Overview of venous thrombosis in inflammatory bowel disease" 21 : 1195-1203, 2015

      12 Kjeldsen J, "Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease" 33 : 637-643, 1998

      13 Sloan WP Jr, "Life histories of patients with chronic ulcerative colitis: a review of 2,000 cases" 54 (54): 819-822, 1968

      14 Miehsler W, "Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?" 53 : 542-548, 2004

      15 Stadnicki A, "Involvement of coagulation and hemostasis in inflammatory bowel diseases" 10 : 659-669, 2012

      16 Danese S, "Inflammation and coagulation in inflammatory bowel disease: the clot thickens" 102 : 174-186, 2007

      17 Chiarantini E, "Hemostatic abnormalities in inflammatory bowel disease" 82 : 137-146, 1996

      18 Sonoda K, "Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease" 39 : 948-954, 2004

      19 Scarpa M, "Deep venous thrombosis after surgery for inflammatory bowel disease: is standard dose low molecular weight heparin prophylaxis enough?" 34 : 1629-1636, 2010

      20 Weber P, "Coagulation and fibrinolysis in children, adolescents, and young adults with inflammatory bowel disease" 28 : 418-422, 1999

      21 Cognat E, "Cerebral venous thrombosis in inflammatory bowel diseases: eight cases and literature review" 6 : 487-492, 2011

      22 Katsanos AH, "Cerebral sinus venous thrombosis in inflammatory bowel diseases" 106 : 401-413, 2013

      23 Baker ME, "CT depiction of portal vein thrombi after creation of ileal pouch-anal anastomosis" 227 : 73-79, 2003

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2015-03-30 학회명변경 영문명 : 미등록 -> KASID KCI등재
      2015-03-30 학회명변경 영문명 : KASID -> Korean Association for the Study of Intestinal Disease KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2010-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2008-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.54 0.54 0.46
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.4 0.35 0.652 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼